Esther Bridges

5.8k total citations
38 papers, 1.7k citations indexed

About

Esther Bridges is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Esther Bridges has authored 38 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 20 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Esther Bridges's work include Cancer, Hypoxia, and Metabolism (17 papers), Angiogenesis and VEGF in Cancer (7 papers) and Cancer Cells and Metastasis (4 papers). Esther Bridges is often cited by papers focused on Cancer, Hypoxia, and Metabolism (17 papers), Angiogenesis and VEGF in Cancer (7 papers) and Cancer Cells and Metastasis (4 papers). Esther Bridges collaborates with scholars based in United Kingdom, United States and Sweden. Esther Bridges's co-authors include Adrian L. Harris, Helen Sheldon, Alan McIntyre, Sven Påhlman, Chern Ein Oon, Jiliang Li, Ulrike Harjes, Erik Fredlund, Simon Wigfield and Francesca M. Buffa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Esther Bridges

38 papers receiving 1.7k citations

Peers

Esther Bridges

ONCOL

IMMUN

PRM

Chirayu Goswami United States

Lynn Kirkpatrick United States

Kenneth Aldape United States

Anna Kuchnio Belgium

Damien Gerald United States

Allie Fu United States

Luana Schito Canada

Ciro Zanca United States

Adam J. Krieg United States

Alexandra Grassian United States

Chirayu Goswami United States

Esther Bridges

1.1k ×1.0

572 ×0.8

443 ×1.0

ONCOL

161 ×0.8

IMMUN

235 ×1.8

PRM

Citations per year, relative to Esther Bridges Esther Bridges (= 1×) peers Chirayu Goswami

Countries citing papers authored by Esther Bridges

Since Specialization

Citations

This map shows the geographic impact of Esther Bridges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Bridges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Bridges more than expected).

Fields of papers citing papers by Esther Bridges

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Bridges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Bridges. The network helps show where Esther Bridges may publish in the future.

Co-authorship network of co-authors of Esther Bridges

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Bridges. A scholar is included among the top collaborators of Esther Bridges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Bridges. Esther Bridges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bridges, Esther, Nasullah Khalid Alham, Christos E. Zois, et al.. (2024). Cone photoreceptor phosphodiesterase PDE6H inhibition regulates cancer cell growth and metabolism, replicating the dark retina response. SHILAP Revista de lepidopterología. 12(1). 5–5. 2 indexed citations

Zhang, Nan, Yao Jiang, Aik Seng Ng, et al.. (2023). GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent Manner. Cancer Research. 83(20). 3400–3413. 7 indexed citations

Sheldon, Helen, Wei Zhang, Esther Bridges, et al.. (2022). ELTD1 is present in extracellular vesicles derived from endothelial cells as a cleaved extracellular domain which induces in vivo angiogenesis. SHILAP Revista de lepidopterología. 1(8). e52–e52. 4 indexed citations

Michl, Johanna, Yunyi Wang, Stefania Monterisi, et al.. (2022). CRISPR-Cas9 screen identifies oxidative phosphorylation as essential for cancer cell survival at low extracellular pH. Cell Reports. 38(10). 110493–110493. 41 indexed citations

Westbrook, Rebecca L., Esther Bridges, Jennie Roberts, et al.. (2022). Proline synthesis through PYCR1 is required to support cancer cell proliferation and survival in oxygen-limiting conditions. Cell Reports. 38(5). 110320–110320. 43 indexed citations

Monterisi, Stefania, Johanna Michl, Alžbeta Hulı́ková, et al.. (2022). Solute exchange through gap junctions lessens the adverse effects of inactivating mutations in metabolite-handling genes. eLife. 11. 8 indexed citations

Coupe, Nicholas, Esther Bridges, Leticia Campo, et al.. (2022). WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanoma. Cellular Oncology. 46(2). 391–407. 5 indexed citations

Sheldon, Helen, Esther Bridges, Ildefonso Silva, et al.. (2021). ADGRL4/ELTD1 Expression in Breast Cancer Cells Induces Vascular Normalization and Immune Suppression. Molecular Cancer Research. 19(11). 1957–1969. 7 indexed citations

Arnaiz, Esther, Ana Miar, Esther Bridges, et al.. (2021). Differential effects of HIF2α antagonist and HIF2α silencing in renal cancer and sensitivity to repurposed drugs. BMC Cancer. 21(1). 896–896. 5 indexed citations

10.

Bridges, Esther, Helen Sheldon, Evelyn Ramberger, et al.. (2020). RHOQ is induced by DLL4 and regulates angiogenesis by determining the intracellular route of the Notch intracellular domain. Angiogenesis. 23(3). 493–513. 18 indexed citations

11.

Morotti, Matteo, Esther Bridges, Alessandro Valli, et al.. (2019). Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer. Proceedings of the National Academy of Sciences. 116(25). 12452–12461. 105 indexed citations

12.

McIntyre, Alan, Alžbeta Hulı́ková, Ioanna Ledaki, et al.. (2016). Disrupting Hypoxia-Induced Bicarbonate Transport Acidifies Tumor Cells and Suppresses Tumor Growth. Cancer Research. 76(13). 3744–3755. 77 indexed citations

13.

Harjes, Ulrike, Esther Bridges, Kshipra M. Gharpure, et al.. (2016). Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4. Oncogene. 36(7). 912–921. 58 indexed citations

14.

Mohlin, Sofie, Kristoffer von Stedingk, Esther Bridges, et al.. (2015). PI3K–mTORC2 but not PI3K–mTORC1 Regulates Transcription of HIF2A/EPAS1 and Vascularization in Neuroblastoma. Cancer Research. 75(21). 4617–4628. 76 indexed citations

15.

Generali, Daniele, Gabriela Krämer-Marek, Merel Gijsen, et al.. (2014). ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer. Oncotarget. 5(16). 6633–6646. 68 indexed citations

16.

Harjes, Ulrike, Esther Bridges, Alan McIntyre, Barbara A. Fielding, & Adrian L. Harris. (2014). Fatty Acid-binding Protein 4, a Point of Convergence for Angiogenic and Metabolic Signaling Pathways in Endothelial Cells. Journal of Biological Chemistry. 289(33). 23168–23176. 74 indexed citations

17.

Li, Jiliang, Richard C.A. Sainson, Chern Ein Oon, et al.. (2011). DLL4-Notch Signaling Mediates Tumor Resistance to Anti-VEGF Therapy In Vivo. Cancer Research. 71(18). 6073–6083. 187 indexed citations

18.

Bridges, Esther & Adrian L. Harris. (2011). The angiogenic process as a therapeutic target in cancer. Biochemical Pharmacology. 81(10). 1183–1191. 72 indexed citations

19.

Pietras, Alexander, Loen M. Hansford, A. Johnsson, et al.. (2009). HIF-2α maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells. Proceedings of the National Academy of Sciences. 106(39). 16805–16810. 111 indexed citations

20.

Larsson, Anna-Maria, Linda Holmquist Mengelbier, Esther Bridges, et al.. (2008). Hypoxia-Inducible Factor-2α Correlates to Distant Recurrence and Poor Outcome in Invasive Breast Cancer. Cancer Research. 68(22). 9212–9220. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact